Icon

DALVANCE (nda021883)- (EQ 500MG BASE/VIAL)

DALBAVANCIN HYDROCHLORIDE ABBVIE
EQ 500MG BASE/VIAL
Yes No
2028-May-23 2019-May-23
None None
2024-May-23 No
DALVANCE is a lipoglycopeptide antibacterial indicated for the treatment of adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms.
0 0 0
Total Other Developers 13
Drugs with Suitability No
EQ 500MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.